Natalya M. Danchenko
Rueil-malmaison, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Investing in enhanced HIV prevention among young men who have sex with men in Brazil: insights from fiscal health modeling.
Journal: Journal of medical economics
Published: August 02, 2026
The burden of HIV-related stigma on clinical and quality of life outcomes: results from a systematic literature review.
Journal: Health psychology and behavioral medicine
Published: July 31, 2026
Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis.
Journal: Advances in therapy
Published: October 27, 2025
Health care resource utilization and costs among patients with spasticity or cervical dystonia.
Journal: Journal of managed care & specialty pharmacy
Published: December 06, 2023
A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity.
Journal: Toxins
Published: July 18, 2023
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison.
Journal: Journal of medical economics
Published: January 17, 2023
Modelling Long-Term Outcomes and Risk of Death for Patients with Post-Stroke Spasticity Receiving Abobotulinumtoxina Treatment and Rehabilitation Therapy.
Journal: Journal of rehabilitation medicine
Published: July 18, 2022
The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
Journal: Journal of medical economics
Published: June 22, 2022
Comparative efficacy, safety, and cost-effectiveness of abobotulinumtoxinA and onabotulinumtoxinA in children with upper limb spasticity: a systematic literature review, indirect treatment comparison, and economic evaluation.
Journal: Journal of medical economics
Published: August 03, 2021
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 14, 2020
Correction to: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia.
Journal: Journal of clinical movement disorders
Published: August 04, 2020
Last Updated: 09/26/2026